Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control.

Purpose Of Review: The goal of this review is to summarize current literature on electronic glucose management systems (eGMS) and discuss their benefits and disadvantages in the inpatient setting.

Recent Findings: We review different versions of commercially available eGMS: Glucommander™ (Glytec, Greenville, SC), EndoTool (MD Scientific LLC, Charlotte, NC), GlucoStabilizer™ (Medical Decision Network, Charlottesville, VA), GlucoCare™ (Pronia Medical Systems, KY), and discuss advantages such as reducing rates of hypoglycemia, hyperglycemia, and glycemic variability. In addition, eCGMs offer a uniform standard of care and may improve workflows across institutions as well reduce barriers.

Neural expression and post-transcriptional dosage compensation of the steroid metabolic enzyme 17beta-HSD type 4.

Background: Steroids affect many tissues, including the brain. In the zebra finch, the estrogenic steroid estradiol (E2) is especially effective at promoting growth of the neural circuit specialized for song. In this species, only the males sing and they have a much larger and more interconnected song circuit than females.